Withdrawal. After acceptance of the abstract, requests for withdrawal of an abstract must be received in writing to email@example.com by the abstract submission deadline: 12 November 2019 (23:59 CET) Any withdrawal requested after that date will not be considered and the abstract will be published EASL's mission is to be the Home of Hepatology so all who are involved with treating liver disease can realise their full potential to cure and prevent it
In the fifty plus years since EASL was founded, it has grown from a small organization that played host to 70 participants at its first meeting, to becoming the leading liver association in Europe. EASL attracts the foremost hepatology experts as members and has an impressive track record in promoting research in liver disease, supporting wider education and promoting changes in european liver. It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2020, 18:00hrs. CEST). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published. . Abstract Submission Opened: April 1, 2020; Abstract Submission Closed: July 17, 2020; UPDATED! Abstract Notification: Monday, August 31, 2020; Late-breaking Abstract Submission: September 9 - 16, 2020; Download the Abstract Submission guide; NEW: Disclosures for Presenting Authors are REQUIRED in order to submit your abstract. Please be sure to obtain disclosures for your presenting author prior to beginning your submission
General abstract submission for the 2021 meeting closed on Dec. 3, 2020. To give authors the opportunity to submit novel research that was not complete at the general submission deadline, DDW will accept late-breaking abstract submissions from 9 a.m. EDT on March 25, 2021, through 5 p.m. EDT on Thursday, April 1, 2021 2020, European Association for the Study of the Liver (EASL), secondary analyses of data from its Phase 2 NASH study with MGL-3196 (resmetirom) will be presented. Resmetirom is currently in Phase 3 development for the treatment of NASH patients with stage 2-3 fibrosis (ClinicalTrials.gov NCT03900429 and ClinicalTrials.gov/NCT04197479) December 2020 Volume 26, Issue 12 Pages 1558 - 1680. View table of contents Hepatology Communications. December 2020 Volume 4, Issue 12 Pages 1727 - 1880. View table of contents FEATURED CONTENT Call for Nominations -- AASLD welcomes you to nominate your colleagues and/or apply for yourself by January 15, 2021. Learn more . AASLD practice guidelines are developed by a panel of experts. Learn.
Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome and Launches Expanded Access Program . September 1, 2020 at 9:00 AM EDT. PDF Version - Maralixibat would be the first treatment available for use in Alagille syndrome, if approved - Completion of the NDA submission expected in. 2020 marks the 55th European Association for the Study of the Liver (EASL) ILC; however, 2020 has been a year like no other in recent memory, and coronavirus disease (COVID-19) continues to be a major societal challenge, reflected Prof Newsome, EASL Secretary General, host of this year's ILC Opening Ceremony The Company has initiated a rolling NDA submission for maralixibat in the treatment of patients with cholestatic pruritus associated with ALGS and expects to complete the submission in the first. The 2021 ACCEA round opened on Monday 7th December 2020 and will close at 17:00 on Thursday 18th March 2021. DEADLINE for applying for BASL support is 09:00 on MONDAY 1st FEBRUARY 2021. BASL will need to have completed the process of selecting those applicants who will receive our support well before the ACCEA deadline date. If you wish to be considered for a new national award in the 2021. Add to Calendar 2019-10-04 08:00:00 2019-10-05 14:00:00 AASLD / EASL ALD Conference This meeting will bridge critical gaps in ALD diagnosis, management and clinical trial design. 1 W. Wacker Drive Chicago, IL 60601 United States AASLD firstname.lastname@example.org America/New_York publi
Submission of content/data by the user 4.1 If the respective organizer offers it to the user, the user can upload a personal photo or, as part of a congress application, an abstract of his presentation or the entire presentation that the user wishes to give at the congress and/or publish in digital, print or online media to the portal; the user can also have a QR or barcode code with the user. Thanks for your submission. We'll get back to you soon! What we do; Team; News; Careers; Pathologists; Partner with Us; Partner Login. PathAI & Gilead Present Research at ILC 2020 Demonstrating AI Models Accurately and Reproducibly Assess Treatment Response and Disease Progression across Liver Disorders. PathAI's artificial intelligence (AI)-powered pathology models were applied to liver. - Results have been included as supportive data in ongoing rolling NDA submission for treatment of cholestatic et al. GALA EASL 2020; Kamath, et al. Hepatology Communications 2020 4 Elisofon. ABSTRACT SUBMISSION IS NOW OPEN. The deadline for receipt of abstracts is Friday, November 20, 2020. All submitting authors will receive confirmation of their abstract submission via email. Abstracts will be selected for podium presentation or poster presentation based on scientific merit. Notification of acceptance for podium and poster. - European Marketing Authorization Application submission for maralixibat in PFIC2, planned by year-end 2020. - Cash, cash equivalents and investments of $133.7 million. November 12, 2020 09:00 AM.
All accepted ILCA 2020 abstracts will be published online on the ILCA Book of Abstracts and presented at the virtual conference as oral presentations or e-posters. Top scored posters will be selected and poster presenters will be present at the sessions: • Best Clinical Poster Session: Friday, 11 September from 16.05 - 16.35 • Best Basic / Translational Poster Session: Friday, 11. 2020.a meistrivõistluste raames selgusid parimad kõrgkoolid. Eelmise nädala kolmapäeval kogunes sellel aastal viimast korda EASL juhatus. Lisaks teistele aktuaalsetele teemadele ja päevakorra punktidele tunnustati ka Eesti 09. november 2020. Nädalavahetusel toimusid Tartus nii lamades surumise- kui ka maadluse meistrivõistlused. Laupäeval 7. novembril toimusid Ülikooli spordihoones. 21-25 September 2020 Virtual Congress Participant Statistics. 55th EASD Annual Meeting 16-20 September 2019 Barcelona, Spain Participant Statistics. 54th EASD Annual Meeting. 1-5 October 2018. Berlin, Germany. Participant Statistics. 53rd EASD Annual Meeting 11-15 September 2017 Lisbon, Portugal Participant Statistics . 52nd EASD Annual Meeting 12-16 September 2016 Munich, Germany Participant. VBI Vaccines Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral and Poster Presentations at EASL 2020. By VBI August 20, 2020 No Comments. VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that two abstracts featuring data from the Phase 3 program.
Easl conference 2020 Digital ILC 2020 - Digital International Liver Congress 2020 . This year, EASL is holding its flagship event as a lively, immersive, three-day online event: The Digital International Liver Congress™ 2020, taking place 27-29 August 2020. Registration for the Digital ILC 2020 is open until 31 December 2020. All content is. The natural history of cirrhosis is characterised by an asymptomatic compensated phase followed by a decompensated phase, marked by the development of overt clinical signs, the most frequent of which are ascites, bleeding, encephalopathy, and jaundice. The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis The Journal of Hepatology publishes original papers, reviews, case reports and letters to the Editor concerned with clinical and basic research in the field of hepatology.The Journal is published in English. Supplements may be accepted after editorial review. The full text of the Journal of Hepatology is available online via two sources: . Institutional access: If your library has a.
IASLC 2020 World Conference on Lung Cancer (WCLC 2020) of the International Association for the Study of Lung Cancer (IASLC) to be held January 26 - 29, 2021 in the vibrant city of Singapore The Liver Meeting Digital Experience is Nov 13-16, 2020. Registration includes live & on demand educational & abstract content, networking opportunities & more First Published: 21 December 2020; Abstract; PDF; more > more > free access. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Zobair M. Younossi; Aaron B. Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer; Hepatology; Pages: 73-84; First Published: 28 December 2015; Abstract; Full text; PDF; References.
Abstract Submission Guidelines Please read this information carefully before proceeding to the online abstract submission. Only abstracts that meet these guidelines can be accepted for the meeting. 1. IMPORTANT DATES Submission deadline: Monday, 07 December 2020, 23:59 CET Abstracts received after the deadline will not be accepted! Abstracts Review: Monday, 14 December 2020 - Monday, 04. ILC 2020 abstract submission deadline: 19 Nov 2019 (23:59 CET) Soto Admin. Share. next post: Discover EASL Campus - your open-access eLearning hub for hepatology and liver-related disease; Keep up to date with The International Liver Congress TM latest news. Sign up to the ILC newsletter. Scientific programme / Abstracts. ILC.email@example.com. Press. firstname.lastname@example.org. EASL Office. EASL supports young investigators (YI), nurses and Allied Health Professionals (AHPs) by helping them to attend all EASL meetings. Types of abstract bursaries YI Full bursaries YI Registration bursaries • ILC 2020 registration fees free of charge • the presenting author EUR 650 each will be attributed to the presenting author of the best 200 scored abstracts • Free EASL membership for. The abstract submission deadline for the EASL / AASLD HBV Endpoints conference in London, UK [March 8-9, 2019] is Monday, December 10. Learn more and submit your abstract. https://bit.ly/2Essv7 Webinar: AASLD-ALEH COVID-19 and Liver Disease in the Americas: 2020 - 2021 and Beyond Emerging Topic Conference - Chronic Hepatitis B: From the Population to New Molecules and Back AASLD / FDA DILI Conference Fundamentals of Liver Disease Visit the full calendar to see all upcoming events! View Full Calendar LiverLearning®, the official eLearning portal of AASLD, offers a variety of online.
CONSHOHOCKEN, Pa., August 26, 2020 -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today that on Friday, August 28, 2020 at the Digital International Liver Congress ™ 2020, European Association for the Study of the Liver (EASL), secondary analyses of data from its Phase 2 NASH study with MGL-3196 (resmetirom) will be presented Abstract Submission Opportunities. Virtual ISPOR 2021 May 15-19, 2021 Abstract Submission Opens: October 22, 2020 Abstract Submission Deadline: - Issue Panel/Workshop Proposals: December 16, 2020 - Research Abstracts: January 13, 2021 Author Notification Call for Invited Programs Site is Now Closed. Submission Status will be Sent by October 9, 2020. Update on 2021 Process In moving ATC 2020 to a Virtual experience, there were a number of ATC 2020 Invited Symposia that were unable to be presented in the virtual space. The intent is to begin the selection of invited programs for 2021 by reviewing the programs accepted for 2020 that were not. FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 1, 2020-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases today announced that it has submitted the first portion of its rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for maralixibat
Contact European Academy of Neurology. Breite Gasse 4/7 1070 Vienna Austria Tel.: +43 1 889 05 03 Fax.: +43 1 889 05 03 13. Email: email@example.com (ZVR-120490024 2020/12/16 Invitation for application of 3rd APASL Awards 【DON'T MISS IT!!】 Deadline for application has been extended to March 1st 2021! To apply, just download the attached application form and [Read more] What's New. Highlights of Past Meetings. The APASL Hepatology Webinar 4-7 has been successfully held! Thank you for taking part on our APASL Hepatology Webinar! The video of. Following the success of the November 2020 virtual forum the BLNA are planning to hold a second webinar in the afternoon on Friday 26th February 2021. Further details will be announced soon. March 2021 . 12 Mar - 13 Mar TASL - BASL Monothematic Conference - Save the Date more. SAVE THE DATE. Turkish and British Associations for the Study of the Liver (TASL-BASL) are pleased to announce a. The FNM 2020 Organising Committee invites you to submit your late breaking abstract for the upcoming Federation of Neurogastroenterology & Motility Meeting. We welcome the submission of abstracts in all areas related to basic, clinical and translational aspects of neurogastroenterology and motility. The following sections provide guidelines for. Abstracts were accepted for presentation at DDW 2021 until Thursday, Dec. 3, 2020, at 9 p.m. EST (21:00 Eastern Time (UTC -5).. To give authors the opportunity to submit novel research that was not complete at the general submission deadline, DDW will accept late-breaking abstract submissions from 9 a.m. EDT on March 25, 2021, through 5 p.m. EDT on Thursday, April 1, 2021
- Maralixibat would be the first treatment available for use in Alagille syndrome, if approved - Completion of the NDA submission expected in the first quarter of 2021 - Expanded Access Program for maralixibat now open FOSTER CITY, CA, USA I September 01, 2020 I Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel. The 2020 EASL budget is $109,100, a slight increase from 2019's budget of $102,000 due in part to increases in line item funding for the Cowan scholarship (whboth ich is now sponsored solely by EASL) and diversity event s. A copy of the 2020 budget, which was distributed at today's EASL EC Meeting , will be attached to today's minutes. Barry reminded the EC members that each committee has. The ESMO Virtual Congress 2020 will present promising new developments aimed at improving cancer patient care. In response to the needs of the moment, the scientific programme will include a dedicated COVID-19 and cancer research track. Take part in Europe's most prestigious platform for oncology stakeholders. Key Dates. Official Programme: Science weekend: 19-21 September 2020 Education.
The Asian Pacific Association for the Study of the Liver (APASL) STC Myanmar 2020. Home; Conference Overview; Organization; Program; Call for Abstract; Registration; Accommodation; Sponsorship & Exhibition; About MYANMAR; December 5-6, 2020. News . Discover Myanmar! Abstract Submission is now available! Pre-Registration is now available! APASL STC 2020 Myanmar Flyer can be downloaded! No event. 02 Mar 2020 End date 04 Mar 2020 Location Paris, France The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research. Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make.
- Results have been included as supportive data in ongoing rolling NDA submission for treatment of cholestatic et al. GALA EASL 2020; Kamath, et al. Hepatology Communications 2020 4 Elisofon. Join the European Stroke Organisation and the World Stroke Organization for their jointly organised virtual conference ESO-WSO, 7-9 November 2020
ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA. ILCA 2020 Virtual Conference will be the premier forum for clinical, translational and basic researchers and physicians, as well as allied professionals across liver cancer-related disciplines to share best practices and findings and advance research in the pathogenesis, prevention, and treatment of liver cancer ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), is exhibiting at The Digital International Liver Congress (ILC), hosted by the European Association for the Study of the Liver (EASL), Aug. 27-29, 2020. Clinical conferences and trade shows continue to be a key component of our.
- Initiated rolling NDA submission and launched Expanded Access Program for maralixibat in Alagille syndrome. - Presented five-year transplant-free survival data for patients with PFIC2 at Digital International Liver Congress (EASL). - European Marketing Authorization Application submission for maralixibat in PFIC2, planned by year-end 2020. - Cash, cash equivalents and investments of $133.7. Australian player handed 12-month ban due to false ID submission . Article. 41 3 months 4 weeks ago by Josh Folland in: Counter-Strike. Our CS:GO plan for the remainder of 2020. Calendar TL;DR: Update: ESL One Rio 2020 Major October: IEM New York 2020 - Online November: IEM Beijing-Haidian 2020 - Online December: IEM Global Challenge 2020. Article. 76 10 months 4 weeks ago by Axel Houstoun in. Please note that general abstracts submission closed on 6 May 2020. Thank you for your submissions. Late-breaking abstracts submission closes on 30 June 2020. Submitting authors will be notified by the end of May 2020 (and late-breaking in July 2020) whether their abstract has been accepted, and they will be informed at the same time about the date, time and form of their presentation. All. support the planned subpart H submission to FDA for accelerated approval. Becky Taub, M.D., Chief Medical Officer and President of Research & Development . of Madrigal, stated, As shown in our EASL abstract publication now rescheduled for oral presentation at the end of August, fat reduction as measured by week 12 MRI-PDFF predicts NASH resolution on biopsy at week 36. This finding.
GESA AGW 2020 Virtual. Welcome to our 1200 + delegates that have joined us for AGW 2020. One of the benefits of being virtual is that for those who were not able to see all of the sessions they are available for viewing on demand - following the live session - to registered attendees only. To view a session simply: Access the AGW Virtual platform using your personal OnAIR details. Abstract and clinical case submission for the upcoming ERS congress is open now until 11 February, 2021. We are also accepting proposals for hot topic sessions until 7 March, 2021. Learn more and submit: Abstract submission; Clinical case submission; Hot topic session proposals; Hotel accommodation. The official hotel accommodation partner is B-Network. Please contact B-Network directly for.
Let's meet, discuss and exchange virtually during the ECTS 2020 Digital Congress. Enjoy 3-days of cutting-edge and lively exchanges at the Live Prime Time from 22-24 October 2020, and immerse yourself in additional educational content delivered directly to you during ECTS@Home weekly classes, starting in September.. All at your fingertips and this year at a very special registration rate, so. Become an EASL member as of 1 October 2019 and before 14 January 2020 to enjoy reduced fees to the International Liver Congress™ 2020. New members as of 15 January 2020 are not eligible for the.
Thursday, Oct. 15, 2020, at 9 a.m. EDT: Abstract submission site opens. Thursday, Dec. 3, 2020, at 9 p.m. EST: Abstract submission site closes. No abstract edits, author additions or changes to author information will be accepted after this deadline. Please note this deadline occurs on the Thursday after the U.S. Thanksgiving holiday. Thursday, Dec. 17, 2020, at 3 p.m. EST: Co-author. Below is a recent list of 2020—2021 articles that have had the most social media attention. The Plum Print next to each article shows the relative activity in each of these categories of metrics: Captures, Mentions, Social Media and Citations. Go here to learn more about PlumX Metrics Abstract Submission for the Paris 2020 Congress is open! You can find details and guidelines on how to submit an abstract on the congress website here. The Abstract Submission deadline is 8 January 2020- submit your abstract today! If you have any questions, please contact firstname.lastname@example.org Submission deadline: Friday, 9 October 2020 (23:59 AoE) Author notification: Friday, 30 October 2020 (23:59 AoE) We welcome original research papers of up to 4 pages in length (not including references or supplementary materials), formatted according to the NeurIPS 2020 style. $150,000 Призовой фонд. Location: The workshop will be held virtually due to risks and travel restrictions. General abstract submission for the 2021 meeting closed on Dec. 3, 2020. To give authors the opportunity to submit novel research that was not complete at the general submission deadline, DDW will accept late-breaking abstract submissions from 9 a.m. EDT on March 25, 2021, through 5 p.m. EDT on Thursday, April 1, 2021. Submit Your Abstract . Read Submission Guidelines. Learn About DDW 2021.
Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholi The year 2020 is commonly used by science-fiction writers to make predictions about the future. Similarly, the ISOQOL 2020 annual conference provides an ideal opportunity for the ISOQOL community to look forward.The 2020 conference will focus on important developments in collecting, analyzing, interpreting and disseminating patient-centered outcomes data, with an emphasis on what the future. We very much look forward to welcoming you to a virtual IHPBA 2020 in November. Until then, stay safe and healthy. Prof Martin Smith President, IHPBA: Prof Christopher Christophi President, A-PHPBA IHPBA 2020 Congress Chair: Dr Tom Wilson President, ANZHPBA: Registration starting from USD150. Register Now . CONGRESS HOST BODIES. PROGRAM DESIGNED FOR YOU BY LEADING MINDS. View Program. Contact. Best of The Liver Meeting 2020 The Liver Meeting Digital Experience Webinar: Practical Approach to Coagulation Management in Cirrhosis Webinar: To Stop or Not to Stop: The Practice of Finite Nucleos(t)ide Analog Therapy Webinar: COVID-19 Vaccination in Patients with Liver Disease Webinar: Developing a Career in Clinical Research Webinar: Use of Serum and Imaging Biomarkers of NAFLD/NASH in. If you have queries regarding online submission or abstract related matters, please email us at email@example.com. The last date of abstract submission is 28 February 2021. You will be notified about the decision of acceptance (or rejection) by 30 April 2021. Submit Your Abstracts Now . Stay tuned! Don't miss an update from APDW 2021 . For any enquiry e-mail at secretariat@apdwkl2021.
ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a. 2020 Call for Late-Breaking Abstracts . Information for authors interested in submitting abstracts for the ASH Annual Meeting. Learn More. Abstract Review Categories . Categories that all research and/or studies submitted must fall into. Learn More. ASH Abstract Achievement Awards and Outstanding Abstract Achievement Awards. Dear neurologists, other healthcare professionals, and neuroscientists, Dear colleagues and friends. In the interest of the health, safety and well-being of all registered attendees, our patients and families, as well as the general public, the European Academy of Neurology (EAN) has decided to cancel all in-person attendance and face-to-face activities at the Annual Congress, of May 23-26.
- Maralixibat would be the first treatment available for use in Alagille syndrome, if approved - Completion of the NDA submission expected in the first quarter of 2021 - Expanded Access Program for maralixibat now open FOSTER CITY, CA, USA I September 01, 2020 I Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel. VBI Vaccines : Sci-B-Vac® Phase 3 Data at EASL 2020. 08/31/2020 | 08:14am EST *: *: * VBI Vaccines Inc. (Nasdaq: VBIV) (VBI VBI VACCINES: Announces Submission of Marketing Authorization Application for 3.. BU. 11/19: VBI-1901: SNO Phase 2a Data & Clinical Update: PU. 11/19: VBI VACCINES: Announces Positive Interim Phase 2a Data from VBI-1901 in Recurre.. BU. 11/18: VBI VACCINES: Announces. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), is exhibiting at The Digital. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), is exhibiting at The Digital International Liver Congress (ILC), hosted by the European Association for the Study of the Liver (EASL), Aug. 27-29, 2020. Clinical conferences and trade shows continue to be a key component of our brand. London 19-23 January 2020. Registration now open 19 Jan 2020. Continue reading . 16th EADV Symposium. 30th April - 2nd May 2020 - Porto, Portugal in Centro de Congressos da Alfândega do Porto 30 Apr 2020. Continue reading . 27. Fortbildungswoche für praktische Dermatologie und Venerologie. Das virtuelle KONGRESSERLEBNIS | 07. - 11. Juli 2020 07 Jul 2020. Continue reading . 32rd Congress of.
Overall, 165 travel-related HEV infections were reported, mainly since 2010 (60%) and in tourists (50%). Travellers were exposed to hepatitis E in 27 countries; most travellers (62%) were exposed to HEV in South Asia Add to Calendar 2020-11-13 09:00:00 2020-11-16 14:00:00 The Liver Meeting Digital Experience The Liver Meeting® is the annual must-attend event bringing together attendees from around the world to exchange the latest research, discuss new developments in treatment outcomes, and network with other experts in the field. AASLD firstname.lastname@example.org America/New_York public. Register. Em 2020, tivemos em Bali na Indonésia a conferência que foi um sucesso. As próximas agendas serão conforme o calendário internacional 2021 (30th) Bangkok Dr. Tawesak Tanwandee 2022 (31st) Seoul Dr. Ji Mon Yang 2020 (33rd) Guangzhou Dr. Xiaolong Qi Portal Hypertension — [ ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020. August 27, 2020 GMT. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (″ENDRA″) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), is exhibiting at The Digital International Liver Congress (ILC), hosted by the European Association for the Study of. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), is exhibiting at The Digital International Liver Congress (ILC), hosted by the European Association for the Study of the Liver (EASL), Aug. 27-29, 2020. 'Clinical conferences and trade shows continue to be a key component of our brand. ANN ARBOR, MI / ACCESSWIRE / August 27, 2020 / ENDRA Life Sciences Inc. ('ENDRA') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), is exhibiting at The Digital.